Cresco Labs Inc. (CRLBF)
OTCMKTS
· Delayed Price · Currency is USD
0.5020
-0.0063 (-1.24%)
Jun 27, 2025, 3:59 PM EDT
Cresco Labs Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| 697.32 | 715.76 | 756.06 | 824.93 | 805.68 | 463.08 | Upgrade
| |
Revenue Growth (YoY) | -6.69% | -5.33% | -8.35% | 2.39% | 73.98% | 272.87% | Upgrade
|
Cost of Revenue | 354.93 | 359.89 | 408.52 | 430.2 | 375.9 | 252.63 | Upgrade
|
Gross Profit | 342.38 | 355.87 | 347.54 | 394.73 | 429.79 | 210.45 | Upgrade
|
Selling, General & Admin | 222.69 | 220.75 | 247.08 | 309.86 | 276 | 198.65 | Upgrade
|
Other Operating Expenses | - | - | - | - | 16 | 13.17 | Upgrade
|
Operating Expenses | 246.01 | 243.92 | 282.01 | 330.5 | 313.6 | 228.95 | Upgrade
|
Operating Income | 96.38 | 111.95 | 65.53 | 64.23 | 116.18 | -18.5 | Upgrade
|
Interest Expense | -59.72 | -58.9 | -63.62 | -58.52 | -52.15 | -32.64 | Upgrade
|
Interest & Investment Income | 2.99 | 2.92 | 2.8 | 0.68 | 0.94 | 1.41 | Upgrade
|
Earnings From Equity Investments | - | - | - | - | -1.2 | -1.18 | Upgrade
|
Currency Exchange Gain (Loss) | 0.71 | 1.04 | -0.3 | 0.93 | -1.23 | -1.42 | Upgrade
|
Other Non Operating Income (Expenses) | -65.26 | -65.36 | -1.91 | -0.7 | 26.91 | -5.61 | Upgrade
|
EBT Excluding Unusual Items | -24.9 | -8.35 | 2.5 | 6.62 | 89.46 | -57.93 | Upgrade
|
Merger & Restructuring Charges | 0.13 | 0.13 | - | -5.47 | -27.64 | -3.75 | Upgrade
|
Impairment of Goodwill | - | - | -50.86 | -117.02 | -215.55 | - | Upgrade
|
Gain (Loss) on Sale of Investments | -0.02 | 0.01 | -0.41 | -4.59 | 1.29 | -0.16 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.96 | -0.68 | 0.76 | 12.31 | -1.11 | -0.13 | Upgrade
|
Asset Writedown | -2.32 | -2.32 | -100.16 | -23.63 | -90.34 | -1.22 | Upgrade
|
Legal Settlements | 0.27 | 0.27 | - | - | - | - | Upgrade
|
Other Unusual Items | -1 | -1 | 1.26 | 4.88 | -12.83 | -0.98 | Upgrade
|
Pretax Income | -27.48 | -10.62 | -146.9 | -126.91 | -256.73 | -64.17 | Upgrade
|
Income Tax Expense | 46.19 | 49.87 | 32.95 | 88.94 | 40.11 | 28.6 | Upgrade
|
Earnings From Continuing Operations | -73.67 | -60.49 | -179.85 | -215.84 | -296.83 | -92.77 | Upgrade
|
Minority Interest in Earnings | -10.01 | -13.95 | 4.33 | 3.8 | -22.76 | -9.39 | Upgrade
|
Net Income | -83.68 | -74.44 | -175.52 | -212.05 | -319.6 | -102.16 | Upgrade
|
Net Income to Common | -83.68 | -74.44 | -175.52 | -212.05 | -319.6 | -102.16 | Upgrade
|
Shares Outstanding (Basic) | 348 | 345 | 324 | 298 | 262 | 210 | Upgrade
|
Shares Outstanding (Diluted) | 348 | 345 | 324 | 298 | 262 | 210 | Upgrade
|
Shares Change (YoY) | 4.38% | 6.69% | 8.61% | 13.66% | 24.64% | 77.88% | Upgrade
|
EPS (Basic) | -0.24 | -0.22 | -0.54 | -0.71 | -1.22 | -0.49 | Upgrade
|
EPS (Diluted) | -0.24 | -0.22 | -0.54 | -0.71 | -1.22 | -0.49 | Upgrade
|
Free Cash Flow | 104.94 | 112.99 | 3.18 | -64.29 | -79.39 | -95 | Upgrade
|
Free Cash Flow Per Share | 0.30 | 0.33 | 0.01 | -0.22 | -0.30 | -0.45 | Upgrade
|
Gross Margin | 49.10% | 49.72% | 45.97% | 47.85% | 53.34% | 45.45% | Upgrade
|
Operating Margin | 13.82% | 15.64% | 8.67% | 7.79% | 14.42% | -3.99% | Upgrade
|
Profit Margin | -12.00% | -10.40% | -23.21% | -25.70% | -39.67% | -22.06% | Upgrade
|
Free Cash Flow Margin | 15.05% | 15.79% | 0.42% | -7.79% | -9.85% | -20.52% | Upgrade
|
EBITDA | 153.05 | 171.05 | 128.04 | 116.16 | 154.82 | 13.29 | Upgrade
|
EBITDA Margin | 21.95% | 23.90% | 16.93% | 14.08% | 19.22% | 2.87% | Upgrade
|
D&A For EBITDA | 56.67 | 59.1 | 62.51 | 51.93 | 38.64 | 31.79 | Upgrade
|
EBIT | 96.38 | 111.95 | 65.53 | 64.23 | 116.18 | -18.5 | Upgrade
|
EBIT Margin | 13.82% | 15.64% | 8.67% | 7.79% | 14.42% | -3.99% | Upgrade
|
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.